News
Advances In Diagnosis And Treatment
2+ hour, 45+ min ago (224+ words) This final research blog will focus on two tests (liquid biopsies and patient-derived organoids) that are being trialled for the diagnosis and follow up of prostate cancer. There is also a spotlight on two novel therapeutic approaches (an immunotherapy agent…...
Around 610, 000 People Are Diagnosed with Bladder Cancer Every Year - Kenyan Network of Cancer Organizations
3+ hour, 59+ min ago (84+ words) Kenyan Network of Cancer Organizations shared a post on Linked In: "Did you know? Annual Incidence in Kenya: ~547 new cases Around 610, 000 people are diagnosed with bladder cancer every year, and many more are living with the disease worldwide. Awareness and…...
Latest advances in urologic ultrasound therapy shared at KSUU annual conference
2+ hour, 55+ min ago (243+ words) The Korean Society for Urological Ultrasonography (KSUU) held its 19th annual academic conference on Sunday at the CHA Bio Complex in Seongnam, Gyeonggi Province. Key topics included surgical techniques for benign prostatic hyperplasia (BPH), management of complex scrotal and testicular conditions,…...
Frontiers | Integrative oncology along with systemic cancer therapies in advanced bladder and prostate cancer: metabolic optimization guiding the shift from palliative care to clinical remission " a case report
3+ hour, 20+ min ago (444+ words) Hundred Years of The Warburg Effect, Metabolic Hallmark of Cancer Cells: Progress in the Prevention, Treatment and Targeted Therapy of Cancer Front. Oncol. , 18 May 2026 The patient then decided against undergoing chemotherapy and went for self-herbal remedies for 4 months (October 2023- March…...
Doctors may have found an easier way to treat prostate cancer " could become new "standard of care" - AOL
10+ hour, 14+ min ago (542+ words) Less is more in the case of this cancer treatment. The most common form of cancer among men in the US, after skin cancer, prostate cancer often comes with traditional treatments that cause difficult side effects. Now, a recent study…...
SA faces critical shortage of urologists
4+ hour, 29+ min ago (266+ words) JOHANNESBURG - South Africa is facing a critical shortage of urologists, with growing concern about declining interest in the field. Fewer than ten people in the country have completed Ph Ds in urology, and there are currently fewer than 300 registered specialists,…...
Pantoprazole Erectile Dysfunction Reddit: Real User Experiences and What to Know
15+ hour, 26+ min ago (14+ words) stat. gov. pl...
AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA" (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer
5+ hour, 40+ min ago (666+ words) WHIPPANY, N. J. --(BUSINESS WIRE)--New data from the Phase II ARASEC trial show NUBEQA" (darolutamide) plus androgen deprivation therapy (ADT) resulted in a 71% reduction in the risk of progression or death per CHAARTED criteria compared to ADT alone (HR 0. 29; 95% CI 0. 200. 40; P…...
Signatera" CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC)
5+ hour, 38+ min ago (699+ words) Bio Space Signatera" CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC) Marks the first FDA-approved use of personalized molecular residual disease (MRD) testing to guide treatment decisions Solidifies Natera's Treatment on MRD (TOMR) approach…...
New PSMAddition data show 58% lower risk of PSA progression with Pluvicto" in metastatic hormone-sensitive prostate cancer " Weekly Voice
14+ hour, 59+ min ago (87+ words) New PSMAddition data show 58% lower risk of PSA progression with Pluvicto" in metastatic hormone-sensitive prostate cancer Weekly Voice The Largest South Asian News Platforms since 1997 Basel, May 17, 2026 " Novartis today announced new data from PSMAddition demonstrating improved prostate-specific antigen (PSA) responses…...